肝细胞肝癌合并微血管癌栓的研究进展

Research progress of microvascular invasion in hepatocellular carcinoma

肝细胞肝癌（简称肝癌）是常见的恶性肿瘤之一，即使行根治性手术治疗，预后依然较差。微血管癌栓（MVI）是一种恶性的肿瘤生物学行为，是影响肝癌根治术后肿瘤复发与患者生存最重要的原因，已越来越受到临床医师的关注和重视。早期识别MVI发生，并选择合理方法及早干预，将有望减少患者术后肿瘤复发，提高远期生存率。笔者就肝癌合并MVI的研究进展进行综述。

Hepatocellular carcinoma is one of the most common malignancies in the worldwide. Selected patients with hepatocellular carcinoma are candidates for curative resection, but nevertheless there is a high risk of tumor recurrence. Micro- vascular invasion （MVI） is an aggressive biological behavior and has repeatedly been identified as a risk factor for prognosis after curative treatment, meanwhile, it is now becoming increasingly concerned . It would be of great significance to distinguish MVI in an early stage and choose an appropriate treatment timely to get a definite improvement for the long-term survival in patients with hepatocellular carcinoma after curative treatment. This review focuses on some certain issues of MVI.